Supernus Pharmaceuticals (SUPN) Work In Process (2013 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Work In Process of $27.2 million for Q2 2026, up 73.57% year-over-year from $15.6 million in Q2 2025, and down 24.65% on a QoQ basis from $36.1 million in Q1 2026.
Supernus Pharmaceuticals (SUPN) Work In Process (2013 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Work In Process for 14 years, with the latest figure at $27.2 million in Q2 2026.
- Work In Process for Q2 2026 came in at $27.2 million, up 73.57% year-over-year; the trailing twelve-month figure through Jun 2026 was $27.2 million (up 73.57% YoY), and the FY2025 annual result was $29.4 million, up 10.14% from the prior year.
- Work In Process eased to $27.2 million in Q2 2026, from $36.1 million in the prior quarter.
- Over five years, Work In Process peaked at $46.2 million in Q1 2022 and troughed at $15.6 million in Q2 2025.
- A 5-year average of $28.8 million and a median of $27.6 million in 2024 frame the typical range for Work In Process.
- The widest annual swing landed in 2022, when Work In Process surged 395.38%; it then slumped 36.0% in 2023.
- A 5-year view of Work In Process shows it stood at $31.7 million in 2022, then decreased by 1.57% to $31.2 million in 2023, then decreased by 14.38% to $26.7 million in 2024, then increased by 10.14% to $29.4 million in 2025, then retreated by 7.72% to $27.2 million in 2026.
- Per Business Quant data, the three most recent Work In Process figures were $27.2 million in Q2 2026, $36.1 million in Q1 2026, and $29.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.37 Bn | 185.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.16 Mn |
| Mar 31, 2026 | 36.05 Mn |
| Dec 31, 2025 | 29.44 Mn |
| Sep 30, 2025 | 33.41 Mn |
| Jun 30, 2025 | 15.65 Mn |
| Mar 31, 2025 | 18.69 Mn |
| Dec 31, 2024 | 26.73 Mn |
| Sep 30, 2024 | 28.10 Mn |
| Jun 30, 2024 | 23.59 Mn |
| Mar 31, 2024 | 23.25 Mn |
| Dec 31, 2023 | 31.21 Mn |
| Sep 30, 2023 | 26.97 Mn |
| Jun 30, 2023 | 23.59 Mn |
| Mar 31, 2023 | 33.98 Mn |
| Dec 31, 2022 | 31.71 Mn |
| Sep 30, 2022 | 25.46 Mn |
| Jun 30, 2022 | 36.86 Mn |
| Mar 31, 2022 | 46.22 Mn |
| Dec 31, 2021 | 45.71 Mn |
| Sep 30, 2021 | 37.91 Mn |